Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Palestinians cancel deal for near-expired COVID vaccines from Israel

Published 18/06/2021, 21:49
Updated 18/06/2021, 21:55
© Reuters. FILE PHOTO: A Palestinian labourer who works within Israel or its settlements in the occupied West Bank, is vaccinated at an Israeli facility at Shaar Efraim crossing from Israel to the West Bank, March 8, 2021. REUTERS/ Ammar Awad

(Corrects to show that 55% of Israel's entire population of 9.3 million people are fully vaccinated, rather than 55% of its age-eligible population, paragraph 11)

By Ali Sawafta and Rami Ayyub

RAMALLAH, West Bank/TEL AVIV (Reuters) - The Palestinian Authority (PA) cancelled a deal on Friday to receive soon-to-expire COVID-19 vaccines from Israel after an initial Israeli shipment showed an expiration date sooner than had been agreed, the PA health minister said.

Israel and the PA announced a vaccine swap deal earlier on Friday that would have seen Israel send up to 1.4 million Pfizer-BioNTech doses to the PA, in exchange for receiving a reciprocal number of doses from the PA later this year.

The doses were due to "expire soon", Israeli Prime Minister Naftali Bennett's office said in a statement announcing the deal. The PA said they had been "approved in order to speed up the vaccination process" in the occupied West Bank and Gaza.

"They told us the expiration date was in July or August, which would allow lots of time for use," PA Health Minister Mai Alkaila told reporters later on Friday.

"But (the expiration) turned out to be in June. That's not enough time to use them, so we rejected them," she said.

The PA cancelled the deal over the date issue, a PA spokesman said, and sent the initial shipment of around 90,000 doses back to Israel.

Bennett's office did not immediately respond to a request for comment.

Rights groups have criticised Israel, which led one of the world's swiftest vaccination campaigns, for not doing more to ensure Palestinian access to doses in the West Bank and Gaza, territory it captured in a 1967 war.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Israeli officials argue that under the Oslo peace accords, the PA health ministry is responsible for vaccinating people in Gaza and parts of the West Bank where it has limited self-rule.

The vaccine deal was among initial policy moves towards the Palestinians by Bennett, who was sworn in on Sunday and replaced veteran leader Benjamin Netanyahu.

Around 55% of Israel's 9.3 million population are fully vaccinated - a coverage rate largely unchanged by this month's expansion of eligibility to include 12- to 15-year-olds.

Some 30% of eligible Palestinians in the West Bank and Gaza, home to a combined 5.2 million people, have received at least one vaccine dose, according to Palestinian officials.

According to a poll released on Tuesday by the Palestinian Center for Policy and Survey Research, 40% of Palestinians are willing to take the vaccine once it is available, while 35% say they and their families are not willing to get vaccinated.

The Palestinians have received vaccine doses from Israel, Russia, China, the United Arab Emirates and the global COVAX vaccine-sharing initiative.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.